Mounjaro Cost in Connecticut: published retail list prices for FDA-approved brand-name GLP-1 medications average $1350/month in Connecticut. Weight Method offers compounded semaglutide and tirzepatide programs from $199/month, all-inclusive. Compounded medications are not FDA-approved.
How much does treatment cost in your state?
What drives Mounjaro Cost in Connecticut? Three factors dominate: manufacturer list pricing, pharmacy benefit manager margins, and the insurance tier system that classifies GLP-1 medications as specialty drugs. Even Connecticut patients with coverage face deductibles of $1,000-$6,000 before copay rates apply, and specialty copays of 20-33% translate to hundreds of dollars per month on top of the deductible. Weight Method bypasses this entire structure with direct-pay pricing that eliminates every intermediary between you and your medication.
How can you save on treatment?
For Connecticut residents weighing the cost of GLP-1 treatment, consider the economics beyond the pharmacy bill. Untreated obesity costs the average patient $3,500-$5,000/year in additional healthcare spending — blood pressure medication, diabetes management, joint pain treatment, sleep apnea equipment. At Weight Method's pricing, tirzepatide can effectively pay for itself within 1-2 years through reduced downstream medical costs.
Your Treatment Options
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

